Aurora Spine Corporation

Good day and welcome to the Aurora Spine Fourth Quarter and Financial Year 2024 Results Conference Call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad. To withdraw your question, please press star then two. Please note, this event has been recorded. I would now like to turn the conference over to Adam Lowensteiner with Lytham Partners. Please go ahead.

Thank you, Jacob. Welcome, everyone, and thank you for joining us today to conduct an update with investors and review the financial results for Worst Find for the fourth quarter and fiscal year 2024 ended December 31st, 2024. With us on the call representing the company today are Mr. Trent Northcutt, President and CEO of Aurora Spine, and Mr. Chad Klaus, Chief Financial Officer of Aurora Spine. Before we begin, I would like to remind everyone that statements made during the course of this call may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21A of the Securities Act of 1934. These statements reflect current expectations concerning future events and results Words such as expect, intend, believe, may, will, should, could, anticipate, and similar expressions are words that are used to identify forward-looking statements, but their absence does not mean a statement is not forward-looking. These statements are not guarantees of future performance and are subject to risks and uncertainties and other important factors that could cause actual performance or achievements to be materially different from those projected. For full discussion of these risks, uncertainties, and factors, you are encouraged to read Aurora Spine's documents on file with CDAR, including those set forth in periodic reports filed under the forward-looking statements and risk factors section. Aurora Spine does not intend to update or revise any forward-looking statements, whether as a result of new information for future events or otherwise. On this call, management may refer to EBITDAG, adjusted EBITDAG, adjusted net income, and adjusted EPS, which are not measures of financial performance under generally accepted accounting principles or DAPF. Management believes that these non-GAAP figures, in addition to other GAAP measures, provide meaningful supplemental information regarding the company's operational performance. Investors should recognize that these non-GAAP figures might not be comparable to similarly titled measures of other companies. These measures should not be considered in addition to and not as a substitute for or superior to any other measure of performance prepared in accordance with GAAP. Reconciliation of non-GAAP measures to the most directly comparable GAAP measures in accordance with SEC Regulation G can be found and the company's earnings release. With that, I'd now like to turn the call over to Mr. Trent Northcutt, President and CEO of Aurora Spine. Trent, please proceed.

Thank you, Adam.